Skip to content

healthycontrol.org

healthycontrol.org

PubMed Commons comments on Cochrane Exercise for CFS review (2015)
Commentary on Cochrane’s Exercise review September-October 2018 (via Absolutely Maybe blog)
My complaint to the Cochrane Governing Board about the Cochrane review of Exercise for chronic fatigue syndrome (November 2018)
Correspondence between Cochrane Editor-in-Chief David Tovey and Trygve Ottersen, Acting Director of Norwegian Institute of Public Health October-November 2018
Response to my complaint to the Cochrane Governing Board about the Cochrane review of Exercise for chronic fatigue syndrome
How Cochrane could help improve the quality of primary research (2018)
Reply to David Tovey’s letter about the Exercise for CFS review
The latest on my complaint to Cochrane about the Exercise for Chronic Fatigue Syndrome reviews (April 2019)
Response from the Co-Chairs of the Cochrane Governing Board (May 2019)
Correspondence with the Charity Commission (April-May 2019)
Correspondence between Cochrane Editor-in-Chief David Tovey and Atle Fretheim, Director of the Norwegian Institute of Public Health late May 2019
June correspondence with Cochrane about the Exercise for CFS review (2019)
Correspondence between Cochrane, Gordon Guyatt and Norwegian Institute of Public Health: May-June 2019
Comment on RoB 2: a revised tool for assessing risk of bias in randomised trials (September 2019)
Comment submitted via Cochrane feedback system on Exercise for CFS Review: 11 January 2020
Correspondence with Cochrane about the Exercise for CFS review July 2019-February 2020
Alternative proposal for overview of trials of all treatments for ME (May 2020)
Request to withdraw CBT for CFS review (June 2020)
It’s not only drugs and medical devices that can cause harm
Second comment on Cochrane’s 2008 CBT for CFS review (3 August 2020)
- Second comment on Cochrane’s 2008 CBT for CFS review (3 August 2020)
Request to Cochrane to withdraw two reviews on Exercise therapy and CBT for Chronic Fatigue Syndrome (November 2020)
Cochrane editors concluded that reviews saying that Exercise and CBT may be helpful for ME/CFS could not cause harm to patients, despite new draft NICE guidelines saying they should no longer be used (Feb 2021)
Complaint to Cochrane about Editor-in-Chief: March 2023
Email to Cochrane Governing Board: 24 June 2023
Letter to Toby Lasserson, Deputy Editor-in-Chief, Cochrane
A summary of our paper on exercise therapy and bias caused by lack of blinding
It’s not only drugs and medical devices that can cause harm
Correspondence between Cochrane, Gordon Guyatt and Norwegian Institute of Public Health: May-June 2019
Request to withdraw CBT for CFS review (June 2020)
Commentary on Cochrane’s Exercise review September-October 2018 (via Absolutely Maybe blog)
How Cochrane could help improve the quality of primary research (2018)
Comment submitted via Cochrane feedback system on Exercise for CFS Review: 11 January 2020
Alternative proposal for overview of trials of all treatments for ME (May 2020)
Correspondence with Cochrane about the Exercise for CFS review July 2019-February 2020
Correspondence with Cochrane about the Exercise for CFS review July 2019-February 2020
Correspondence between Cochrane Editor-in-Chief David Tovey and Trygve Ottersen, Acting Director of Norwegian Institute of Public Health October-November 2018
Correspondence between Cochrane Editor-in-Chief David Tovey and Atle Fretheim, Director of the Norwegian Institute of Public Health late May 2019
PubMed Commons comments on Cochrane Exercise for CFS review (2015)
Comment on RoB 2: a revised tool for assessing risk of bias in randomised trials (September 2019)
June correspondence with Cochrane about the Exercise for CFS review (2019)
Correspondence with the Charity Commission (April-May 2019)
Response from the Co-Chairs of the Cochrane Governing Board (May 2019)
Response to my complaint to the Cochrane Governing Board about the Cochrane review of Exercise for chronic fatigue syndrome
Request to Cochrane to withdraw two reviews on Exercise therapy and CBT for Chronic Fatigue Syndrome (November 2020)

A summary of our paper on exercise therapy and bias caused by lack of blinding

Published November 25, 2020By Caroline Struthers

Categorized as Uncategorized

Leave a comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Post navigation

Previous post

Request to Cochrane to withdraw two reviews on Exercise therapy and CBT for Chronic Fatigue Syndrome (November 2020)

Next post

Cochrane editors concluded that reviews saying that Exercise and CBT may be helpful for ME/CFS could not cause harm to patients, despite new draft NICE guidelines saying they should no longer be used (Feb 2021)

Search…

Recent Posts

Email to Cochrane Governing Board: 24 June 2023
Complaint to Cochrane about Editor-in-Chief: March 2023
Preparing a complaint to Cochrane: January 2023
Letter to Cochrane with a suggestion about the update to the Exercise therapy for ME/CFS review: 19 March 2022
Reply from Gill Leng, ex-CEO of NICE, 27 January 2022

Recent Comments

Trial By Error: Lightning Process Star Complains About NICE; Struthers Nudges Cochrane to Keep Up – Trial By Error on Letter to Toby Lasserson, Deputy Editor-in-Chief, Cochrane
Lene Christiansen on Letter to Medical Research Council’s Fiona Watt about 2018 defence of the PACE Trial (July 2021)
Jen on Letter to Medical Research Council’s Fiona Watt about 2018 defence of the PACE Trial (July 2021)
Marit Hjelsvold @ memhj on Cochrane editors concluded that reviews saying that Exercise and CBT may be helpful for ME/CFS could not cause harm to patients, despite new draft NICE guidelines saying they should no longer be used (Feb 2021)
Et historisk vendepunkt – Life with ME by Sissel on Request to Cochrane to withdraw two reviews on Exercise therapy and CBT for Chronic Fatigue Syndrome (November 2020)

healthycontrol.org

Proudly powered by WordPress.